Documented gastrointestinal manifestations in coronavirus disease 2019 (COVID-19) patients include anorexia, nausea, vomiting, abdominal pain, and diarrhea.
Bedside ultrasound appears to be a valuable method of rapidly assessing lung involvement and monitoring disease progression in patients with COVID-19 infections.
Evidence is rapidly emerging that COVID-19 patients may present with a myriad of cardiac complications, including acute myocardial injury, myocarditis, and dysrhythmias (Arentz et al., Clerkin et al., Huang et al.).
Bedside ultrasound may prove to be a sensitive early indicator of lung involvement in patients with coronavirus 2019 (COVID-19) infection.
In support of the evolving healthcare demands and increased need for remote learning, we are waiving the minimum five Module purchase requirement on our SonoSim Personal Solution.
SonoSim is committed to supporting healthcare institutions, training programs, and medical providers around the world respond to the challenge of COVID-19.
Ultrasound education firm SonoSim has launched a curriculum to train nurses on artificial intelligence (AI)-guided ultrasound procedures.
SonoSim, Inc., the world’s leading provider of ultrasound education and training, has officially announced the launch of a comprehensive nurse ultrasound training curriculum designed to support artificial intelligence (AI) guided ultrasound training needs.